- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Patent holdings for IPC class A61P 1/00
Total number of patents in this class: 6570
10-year publication summary
252
|
250
|
237
|
420
|
482
|
570
|
628
|
658
|
673
|
156
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2961 |
69 |
Société des Produits Nestlé S.A. | 9672 |
68 |
Novartis AG | 11238 |
45 |
AstraZeneca AB | 3042 |
40 |
Nestec S.A. | 2777 |
37 |
DSM IP Assets B.V. | 5856 |
36 |
F. Hoffmann-La Roche AG | 7958 |
35 |
The Regents of the University of California | 18943 |
31 |
Janssen Pharmaceutica N.V. | 3839 |
31 |
N.V. Nutricia | 1022 |
30 |
Glycom A/S | 251 |
30 |
Ajinomoto Co., Inc. | 2337 |
29 |
The Johns Hopkins University | 5377 |
28 |
Boehringer Ingelheim International GmbH | 4629 |
27 |
Cedars-Sinai Medical Center | 1088 |
27 |
Raqualia Pharma Inc. | 119 |
27 |
Astellas Pharma Inc. | 1145 |
26 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
26 |
4D Pharma Research Limited | 98 |
24 |
Vertex Pharmaceuticals Incorporated | 1581 |
23 |
Other owners | 5881 |